HairMax Hair Fibers

Results of a 1 year study on over 4,500 consumers provided data on attitudes and action taken by people regarding hair loss and validated the efforts to disseminate vital information for the HairMax LaserComb

Dec 2009

Lexington Intl, manufacturer of the HairMax LaserComb, the only laser phototherapy device cleared for marketing by the FDA, announces the findings of a major 12 month study on hair loss.
Over 4,500 male and female consumers responded to the survey which generated a wealth of data on peoples’ perception of hair loss and the actions they took to treat their condition.

Respondents were asked to complete a 16 question multiple choice survey and were also asked to provide open ended comments at the end. Data generated from the study by age of respondents mirrored the incidence of hair loss found in the general population.

Treatment Patterns

One of the main goals of the survey was to discover which factors influenced their decision to treat their hair loss and what action they took. While the result showed, as expected that over two thirds of respondents were ‘dissatisfied with their appearance’, almost 40% of respondents indicated that lack of confidence or a ‘negative impact on social or job situations’ was a key factor in seeking treatment.

The findings also highlighted how important it is for physicians to become fully knowledgeable about the device as over 45% of respondents visited a doctor and of these 41% sought advice from a dermatologist.

Finally, the study confirmed the cost involved in treating hair loss in that while almost two third of respondents indicated that they spend up to $25 a month in treatment for their hair, almost 20% spend up to $50 per month.

Of those who purchased products to treat their hair loss, almost 50% purchased minoxidil, while almost 40% had purchased vitamins and herbal supplements in an effort to try to ameliorate their condition.

Full Hair Loss Article